Clinical Trial Update: Glycemic Profile in Women With Gestational Diabetes Treated With Glyburide [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating glyburide for glycemic control in gestational diabetes has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gestational Diabetes Mellitus

Drugs mentioned

• Glyburide (glyburide)

Snippet

Sponsor: University of Pittsburgh | Conditions: Gestational Diabetes | Phase 4 | Status: WITHDRAWN